Sanofi Pharmaceutical, Shanghai Guotou Xian Dao, and others establish a private equity investment fund.

According to the Qichacha APP, recently, the Shanghai SanSheng Private Equity Investment Fund Partnership was established with a capital contribution of 750 million yuan. Its business scope includes engaging in equity investment, investment management, asset management, and other activities as a private equity fund. Qichachas equity penetration shows that this partnership is jointly held by Shenyang SanSheng Pharmaceutical Co., Ltd. and Shanghai Guotou Xian Dao Biomedical Private Equity Investment Fund Partnership, among others.